孙玮良;赵黎明;梁浩;栗超跃;

• 1:河南大学人民医院河南省人民医院
• 2:河南省人民医院(郑州大学人民医院)神经外科

摘要(Abstract)：

目的探讨烟雾病的性别、年龄、地区分布特点、临床表现以及外科治疗效果分析。方法回顾性分析2017-01—2019-04河南省人民医院收治的542例烟雾病患者的临床资料,包括性别、年龄、地区分布、临床表现等,分析其手术效果及预后。结果 542例烟雾病患者中,男女比例为1∶1.05(男265/女277);年龄(45±12.7)岁(3～75岁),年龄分布呈现双峰形态,好发于9～11岁儿童及46～51岁成人段;河南南方地区发病率明显高于其他区域,呈区域集中现象。儿童成人均以缺血性症状为主;缺血型以头痛、头晕为主要首发症状,出血型中以脑室出血最常见。432例接收手术治疗的烟雾病患者中,行间接血管重建术66例,联合血管重建术366例,18例围手术期出现并发症,其余均恢复顺利,临床症状得到改善,随访结果良好。结论河南地区烟雾病的发病无明显性别差异,年龄呈双峰分布,成人多见,多为缺血型,纳入病例中儿童均为缺血型;豫南地区发病率明显高于其他地区;个体化脑血管重建术具有明确的疗效。

关键词(KeyWords)： 烟雾病;流行病学;血管重建术;地区分布;临床特征

Abstract:

Keywords:

基金项目(Foundation): 河南省卫生厅科技攻关项目(编号：201503145)

作者(Authors): 孙玮良;赵黎明;梁浩;栗超跃;

参考文献(References)：

• [1] HASUO K,MIHARA F,MATSUSHIMA T.MRI and MR angiography in moyamoya disease[J].J Magn Reson Imaging,1998,8(4):762-766.DOI:10.1002/jmri.1880080403.
• [2] KURODA S,ISHIKAWA T,HOUKIN K,et al.Clinical significance of posterior cerebral artery stenosis/occlusion in moyamoya disease[J].No Shinkei Geka,2002,30(12):1295-1300.
• [3] SUZUKI J,TAKAKU A.Cerebrovascular"moyamoya"disease.Disease showing abnormal net-like vessels in base of brain[J].Arch Neurol,1969,20(3):288-299.DOI:10.1001/archneur.1969.00480090076012.
• [4] Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis;Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases.Guidelines for diagnosis and treatment of moyamoya disease(spontaneous occlusion of the circle of Willis[J].Neurol Med Chir(Tokyo),2012,52(5):245-266.DOI:10.2176/nmc.52.245.
• [5]高坤．河南地区烟雾病临床特征及治疗分析[J]．河南医学研究，2018,5(27):788-792.
• [6] BABA T,HOUKIN K,KURODA S.Novel epidemiological features of moyamoya disease[J].J Neurol Neurosurg Psychiatry,2008,79(8):900-904.DOI:10.1136/jnnp.2007.130666.
• [7] KLEINLOOG R,REGLI L,RINKEL G J,et al.Regional differences in incidence and patient characteristics of moyamoya disease:a systematic review[J].J Neurol Neurosurg Psychiatry,2012,83(5):531-536.DOI:10.1136/jnnp-2011-301387.
• [8] HUANG S,GUO Z N,SHI M,et al.Etiology and pathogenesis of Moyamoya Disease:An update on disease prevalence[J].Int J Stroke,2017,12(3):246-253.DOI:10.1177/1747493017694393.
• [9] KIM T,LEE H,BANG J S,et al.Epidemiology of Moyamoya Disease in Korea:Based on National Health Insurance Service Data[J].J Korean Neurosurg Soc,2015,57(6):390-395.DOI:10.3340/jkns.2015.57.6.390.
• [10] HISHIKAWA T,SUGIU K,DATE I.Moyamoya Disease:A Review of Clinical Research[J].Acta Med Okayama,2016,70(4):229-236.DOI:10.18926/AMO/54497．
• [11] KIM J S.Moyamoya Disease:Epidemiology,Clinical Features,and Diagnosis[J].J Stroke,2016,18(1):2-11.DOI:10.5853/jos.2015.01627.
• [12] AHN I M,PARK D H,HANN H J,et al.Incidence,prevalence,and survival of moyamoya disease in Korea:a nationwide,population-based study[J].Stroke,2014,45(4):1090-1095.DOI:10.1161/STROKEAHA.113.004273．
• [13] CHEN P C,YANG S H,CHIEN K L,et al.Epidemiology of moyamoya disease in Taiwan:a nationwide population-based study[J].Stroke,2014,45(5):1258-1263.DOI:10.1161/STROKEAHA.113.004160.
• [14] MIAO W,ZHAO P L,ZHANG Y S,et al.Epidemiological and clinical features of Moyamoya disease in Nanjing,China[J].Clin Neurol Neurosurg,2010,112(3):199-203.DOI:10.1016/j.clineuro.2009.11.009．
• [15]唐斌．江西地区烟雾病的临床特征及外科治疗分析[J]．中华神经医学杂志，2017,7(16):719-724.DOI:10.3760/cma.j.issn.1671-8925.2017.07.014.
• [16] IKEZAKI K,HAN D H,KAWANO T,et al.A clinical comparison of definite moyamoya disease between South Korea and Japan[J].Stroke,1997,28(12):2513-2517.DOI:10.1161/01.str.28.12.2513.
• [17] IKEZAKI K,FUKUI M,INAMURA T,et al.The current status of the treatment for hemorrhagic type moyamoya disease based on a 1995nationwide survey in Japan[J].Clin Neurol Neurosurg,1997,99(Suppl 2):S183-S186.DOI:10.1016/s0303-8467(97)00077-2.
• [18] LI Q,QU L,YUAN Y,et al.Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of north eastern China:A single-center study of 212cases[J].Biomed Rep,2018,8(2):191-197.DOI:10.3892/br.2017.1030.
• [19] CHENG J H,YE Q,YE Z S,et al.Five-year experience of 101adult patients with moyamoya disease at a single institution in Eastern China[J].J Clin Neurosci,2016,32:30-34.DOI:10.1016/j.jocn.2015.12.042.
• [20] DUAN L,BAO X Y,YANG W Z,et al.Moyamoya disease in China:its clinical features and outcomes[J].Stroke,2012,43(1):56-60.DOI:10.1161/STROKEAHA.111.621300.
• [21] BAO X Y,WANG Q N,ZHANG Y,et al.Epidemiology of Moyamoya Disease in China:Single-Center,Population-Based Study[J].World Neurosurg,2019,122:e917-e923.DOI:10.1016/j.wneu.2018.10.175.
• [22] HOUKIN K,NAKAYAMA N,KURODA S,et al.How does angiogenesis develop in pediatric moyamoya disease after surgery?A prospective study with MR angiography[J].Childs Nerv Syst,2004,20(10):734-741.DOI:10.1007/s00381-004-0971-x.